Malnourishment in the overweight and obese elderly
1Health School. Department of Nutrition and Dietetics. Kirklareli University.
Nutricion Hospitalaria
|March 5, 2019
Summary
Obesity in the elderly can mask malnutrition. A study found nearly half of overweight or obese seniors had malnutrition, highlighting the need for careful nutritional assessment in this population.
Area of Science:
- Gerontology
- Nutrition Science
- Public Health
Background:
- Increasing prevalence of obesity among the elderly population.
- Malnutrition, a syndrome of nutrient deficiency, can be masked by obesity.
- Overweight and obesity in seniors pose significant health risks.
Purpose of the Study:
- To assess malnutrition in overweight and obese elderly individuals.
- Utilize the Mini Nutritional Assessment (MNA) test for nutritional status evaluation.
- Investigate the prevalence of malnutrition in a geriatric cohort with elevated BMI.
Main Methods:
- A cohort of 187 elderly individuals with overweight or obesity was studied.
- Nutritional status was evaluated using the Mini Nutritional Assessment-Short Form (MNA-SF).
- Body Mass Index (BMI) ranged from 25.0 to 48.9 in the sample.
Main Results:
- Nearly half (49.7%) of elderly participants with a BMI over 25 exhibited signs of malnutrition.
- The study included 101 males (54.3%) and 86 females (45.7%).
- Significant variability in Body Mass Index (BMI) was observed within the sample.
Conclusions:
- Overweight and obese elderly individuals are at heightened risk for malnutrition.
- Careful and regular nutritional screening is crucial for this demographic.
- Early detection and intervention are vital for managing health threats in elderly with obesity.
Keywords:
Anciano. Estado nutricional. MNA.
Related Concept Videos
01:24Obesity
1.3K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.3K
01:21Drug Dosing: Obese Patients
254
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
254
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
266
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
266
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
176
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
176